Aims This study aimed to analyse clinical investigation‐device initial submissions received by the MHRA between January 2022 and December 2025. Methods Data on submissions were extracted from the clinical investigations unit data bank; software as medical devices were not included. The predefined primary end‐point was submission type.
Andrea Manfrin +7 more
wiley +1 more source
Edinburgh University Solution of Lime (EUSOL) Versus Platelet-Derived Growth Factor Dressing for Wound Contraction in Grade II Wagner Diabetic Foot Ulcers: A Randomized Controlled Trial. [PDF]
Batool F +5 more
europepmc +1 more source
Self-Driven Drug Release Dual-Layer Dressing Composed of Electrospun Membrane and Hydrogel with Dynamic Structure Based on Piezoelectricity Transformation and Electrical Responsiveness. [PDF]
Wu Q, Zhao Y, Zhu W, Lv F, Si G.
europepmc +1 more source
Methodological and Statistical Concerns Regarding "Nanofiber Matrix Dressing for Split-Thickness Skin Graft Donor Sites" [Response To Letter]. [PDF]
Biskupski M +6 more
europepmc +1 more source
Curcumin (Ferrocene)-Functionalized Polyurethane Composite Dressing Integrated with Dopamine-Grafted Sodium Alginate: Synergistic ROS Modulation and Durable Tissue Adhesion. [PDF]
Yu J +5 more
europepmc +1 more source
Pediatric home-based central venous access device dressings: Medical liquid adhesive versus standard care to reduce dressing disruption: The STICKY-kids RCT protocol. [PDF]
Kleidon TM +5 more
europepmc +1 more source

